Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 99.1 Press Release Dated October 14, 2021 Announcing Clene Nanomedicine Presents Blinded Interim Update from Visionary-ms and Positive Results from Repair-ms Phase 2 Clinical Trials
- 99.2 Slide Presentation Dated October 14, 2021
- 99.3 Poster Dated October 14, 2021
- Download Excel data file
- View Excel data file
CLNN similar filings
- 15 Nov 21 Clene Announces Completion of Patient Enrollment in the HEALEY ALS Platform Trial
- 9 Nov 21 Clene Reports Third Quarter 2021 Operating and Financial Highlights
- 2 Nov 21 Clene Nanomedicine Announces Top-Line Results from
- 14 Oct 21 Clene Nanomedicine Presents Blinded Interim Update from VISIONARY-MS and Positive Results from REPAIR-MS Phase 2 Clinical Trials
- 7 Oct 21 Regulation FD Disclosure
- 29 Sep 21 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
- 23 Sep 21 Clene Announces Initiation of a Second FDA Expanded Access Program with CNM-Au8 for People Living with Amyotrophic Lateral Sclerosis
Filing view
External links
